Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · December 11, 2023

Diagnostic Utility of CSF Biomarkers in Patients With Rapidly Progressive Dementia

Annals of Neurology


Additional Info

Disclosure statements are available on the authors' profiles:

Annals of Neurology
Diagnostic Utility of Cerebrospinal Fluid Biomarkers in Patients with Rapidly Progressive Dementia
Ann. Neurol 2023 Oct 28;[EPub Ahead of Print], LA Kuchenbecker, PW Tipton, Y Martens, MR Brier, N Satyadev, SR Dunham, EB Lazar, MV Dacquel, RL Henson, G Bu, MD Geschwind, JC Morris, SE Schindler, E Herries, NR Graff-Radford, GS Day

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading